表紙
市場調查報告書

冠狀動脈繞道手術:醫療設備的開發平台評估

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 357845
出版日期 內容資訊 英文 149 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈繞道手術:醫療設備的開發平台評估 Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月18日內容資訊: 英文 149 Pages
簡介

本報告提供冠狀動脈繞道手術相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 冠狀動脈繞道手術概要

第3章 開發中的產品

  • 冠狀動脈繞道手術 - 開發中產品:各開發階段
  • 冠狀動脈繞道手術 - 開發中產品:各市場區隔
  • 冠狀動脈繞道手術 - 開發中產品:各地區 (國家)
  • 冠狀動脈繞道手術 - 開發中產品:各法規途徑
  • 冠狀動脈繞道手術 - 開發中產品:各核准時期 (估計)
  • 冠狀動脈繞道手術 - 持續中臨床實驗

第4章 冠狀動脈繞道手術 - 正在開發的開發中產品:各企業

  • 冠狀動脈繞道手術企業 - 開發中產品:各開發階段
  • 冠狀動脈繞道手術 - 開發中產品:各開發階段

第5章 冠狀動脈繞道手術 開發企業與產品概要

  • AdvanSource Biomaterials Corporation
  • Axcelon Biopolymers Corp.
  • CardioPolymers, Inc.
  • CellProthera
  • Coromedic Ltd.
  • Cytograft Tissue Engineering, Inc.
  • Elana bv
  • Endogene Ltd
  • Graft-Loc Inc.
  • H. Lee Moffitt Cancer Center & Research Institute, Inc.
  • iiTech BV
  • Magenta Medical Inc
  • Miracor Medical Systems GmbH
  • Neograft Technologies, Inc.
  • NuVascular Technologies Inc
  • Prekubator TTO
  • Revivicor, Inc.
  • SeamVad Ltd.
  • St. Jude Medical, Inc.
  • Tengion, Inc.
  • The University of Utah
  • Tissue Regeneration Technologies, LLC
  • University College London
  • University of Arizona
  • University of California, Los Angeles

第6章 冠狀動脈繞道手術 - 近幾年趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0879EPD

GlobalData's Medical Devices sector report, "Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Coronary Artery Bypass Graft Surgery Overview 8

3 Products under Development 9

  • 3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 9
  • 3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 10
  • 3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 11
  • 3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 12
  • 3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 13
  • 3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 14

4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies 15

  • 4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 15
  • 4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 17

5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 18

  • 5.1 AdvanSource Biomaterials Corporation Company Overview 18
    • 5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Axcelon Biopolymers Corp. Company Overview 19
    • 5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 CardioPolymers Inc Company Overview 20
    • 5.3.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 Cardious Inc Company Overview 21
    • 5.4.1 Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.5 Centre Hospitalier Universitaire de Nice Company Overview 22
    • 5.5.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.6 Coromedic Ltd. Company Overview 23
    • 5.6.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 25
    • 5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 Elana bv Company Overview 26
    • 5.8.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Graft-Loc Inc. Company Overview 27
    • 5.9.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 28
    • 5.10.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 Hancock Jaffe Laboratories Inc Company Overview 29
    • 5.11.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 iiTech BV Company Overview 30
    • 5.12.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.13 McGill University Company Overview 32
    • 5.13.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.14 Medical 21 Inc Company Overview 33
    • 5.14.1 Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.15 Myocardial Assist Systems and Technology LLC Company Overview 34
    • 5.15.1 Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.16 Neograft Technologies Inc Company Overview 35
    • 5.16.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.17 PetVivo Holdings Inc Company Overview 36
    • 5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.18 RegenMedTX LLC Company Overview 37
    • 5.18.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.19 Rox Medical Inc Company Overview 38
    • 5.19.1 Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.20 SeamVad Ltd. Company Overview 41
    • 5.20.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.21 Surg Solutions SL Company Overview 42
    • 5.21.1 Surg Solutions SL Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.22 Synovis Micro Companies Alliance Inc Company Overview 43
    • 5.22.1 Synovis Micro Companies Alliance Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.23 Thoratec Corp Company Overview 44
    • 5.23.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.24 Tissue Regeneration Technologies LLC Company Overview 45
    • 5.24.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.25 University College London Company Overview 46
    • 5.25.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.26 University Hospital Basel Company Overview 47
    • 5.26.1 University Hospital Basel Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.27 University of Arizona Company Overview 48
    • 5.27.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.28 University of California Los Angeles Company Overview 49
    • 5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.29 University of Utah Company Overview 50
    • 5.29.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 50

6 Coronary Artery Bypass Graft Surgery- Recent Developments 51

  • 6.1 Nov 19, 2019: Hancock Jaffe Medical Team to make presentations at 46th Annual VEITH Vascular Symposium 51
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 51
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 54
  • 6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 55
  • 6.5 Oct 31, 2019: Sanofi Q3 well on track 55

7 Appendix 146

  • 7.1 Methodology 146
  • 7.2 About GlobalData 149
  • 7.3 Contact Us 149
  • 7.4 Disclaimer 149

List of Tables

  • Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • Table 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
  • Table 7: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
  • Table 8: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Table 9: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: CardioPass - Product Status
  • Table 11: CardioPass - Product Description
  • Table 12: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: BNC - PVA Based Vascular Graft - Product Status
  • Table 14: BNC - PVA Based Vascular Graft - Product Description
  • Table 15: CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Plexisyl-AF - Product Status
  • Table 17: Plexisyl-AF - Product Description
  • Table 18: Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: AvA Aortic Valve Bypass Graft System - Product Status
  • Table 20: AvA Aortic Valve Bypass Graft System - Product Description
  • Table 21: Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Shark Anastomosis Connector - Product Status
  • Table 23: Shark Anastomosis Connector - Product Description
  • Table 24: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Distal Anastomosis Device - Product Status
  • Table 26: Distal Anastomosis Device - Product Description
  • Table 27: Proximal Anastomosis Device - Product Status
  • Table 28: Proximal Anastomosis Device - Product Description
  • Table 29: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: LifeLine TEBV - CABG - Product Status
  • Table 31: LifeLine TEBV - CABG - Product Description
  • Table 32: Elana bv Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: ELANA CLIP 3.0 - Product Status
  • Table 34: ELANA CLIP 3.0 - Product Description
  • Table 35: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Graft-Loc Device - Product Status
  • Table 37: Graft-Loc Device - Product Description
  • Table 38: H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Vascular Stent - Product Status
  • Table 40: Vascular Stent - Product Description
  • Table 41: Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: CoreoGraft - Product Status
  • Table 43: CoreoGraft - Product Description
  • Table 44: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: S² Distal Anastomotic System - Product Status
  • Table 46: S² Distal Anastomotic System - Product Description
  • Table 47: S² Proximal Anastomotic System - Product Status
  • Table 48: S² Proximal Anastomotic System - Product Description
  • Table 49: McGill University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Transcatheter Aorta Pulmonary Shunt - Product Status
  • Table 51: Transcatheter Aorta Pulmonary Shunt - Product Description
  • Table 52: Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Artificial Blood Vessel - Product Status
  • Table 54: Artificial Blood Vessel - Product Description
  • Table 55: Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Sutureless Anastomotic Graft Connection Device - Product Status
  • Table 57: Sutureless Anastomotic Graft Connection Device - Product Description
  • Table 58: Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Neovaso - Product Status
  • Table 60: Neovaso - Product Description
  • Table 61: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Coronary Artery Bypass Graft - Product Status
  • Table 63: Coronary Artery Bypass Graft - Product Description
  • Table 64: RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Neo-Vessel Replacement - Coronary Artery Bypass - Product Status
  • Table 66: Neo-Vessel Replacement - Coronary Artery Bypass - Product Description
  • Table 67: Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: ROX Anastomotic Coupler System - Product Status
  • Table 69: ROX Anastomotic Coupler System - Product Description
  • Table 70: Rox Medical Inc - Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
  • Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
  • Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
  • Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
  • Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
  • Figure 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
Back to Top